发明名称 THERAPEUTIC AGENT FOR DRY EYE
摘要 <p>A novel use of a compound represented by the general formula (1) or a salt thereof. The compound represented by the general formula (1) or salt thereof produces an excellent alleviating effect in a corneal disorder healing effect test using a dry eye model. It is useful as a therapeutic agent for dry eye or diseases accompanying dry eye. Symbol A is lower alkylene or lower alkenylene; ring X is a nonaromatic ring or nitrogenous aromatic heterocycle; R&lt;SUP&gt;1&lt;/SUP&gt; is hydrogen or lower alkyl and R&lt;SUP&gt;2&lt;/SUP&gt; is hydroxy, provided that R&lt;SUP&gt;1&lt;/SUP&gt; may be fused to R&lt;SUP&gt;2&lt;/SUP&gt; to form a lactone ring; R&lt;SUP&gt;3&lt;/SUP&gt; is hydrogen or lower alkyl; R&lt;SUP&gt;4&lt;/SUP&gt; is optionally substituted lower alkyl, cycloalkyl, optionally substituted aryl, hydroxy or an ester thereof, lower alkoxy, carboxy or an amide thereof, or lower alkylamino or an amide thereof; and m is an integer of 0-4, provided that when m is 2 or larger, then the R&lt;SUP&gt;4&lt;/SUP&gt;'s may be the same or different.</p>
申请公布号 WO2006064825(A1) 申请公布日期 2006.06.22
申请号 WO2005JP22913 申请日期 2005.12.14
申请人 SANTEN PHARMACEUTICAL CO., LTD.;NAKAMURA, MASATSUGU;HIRAI, SHIN-ICHIRO;SHIBAGAKI, KEIICHI 发明人 NAKAMURA, MASATSUGU;HIRAI, SHIN-ICHIRO;SHIBAGAKI, KEIICHI
分类号 A61K31/22;A61K9/06;A61K9/08;A61K31/351;A61K31/366;A61K31/40;A61K31/4025;A61K31/404;A61K31/44;A61K31/4433;A61K31/47;A61K31/4709;A61K31/505;A61K31/506;A61P27/02 主分类号 A61K31/22
代理机构 代理人
主权项
地址